Sellas Life Net Worth
Sellas Life Net Worth Breakdown | SLS |
Sellas Life Net Worth Analysis
Sellas Life's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Sellas Life's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Sellas Life's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Sellas Life's net worth analysis. One common approach is to calculate Sellas Life's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Sellas Life's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Sellas Life's net worth. This approach calculates the present value of Sellas Life's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Sellas Life's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Sellas Life's net worth. This involves comparing Sellas Life's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Sellas Life's net worth relative to its peers.
Enterprise Value |
|
To determine if Sellas Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sellas Life's net worth research are outlined below:
| Sellas Life Sciences generated a negative expected return over the last 90 days | |
| Sellas Life Sciences may become a speculative penny stock | |
| Sellas Life Sciences has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (37.34 M) with profit before taxes, overhead, and interest of 900 K. | |
| Sellas Life Sciences has about 26.99 M in cash with (31.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Sellas Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from forbes.com: NASA Yule Log Video Stars Four Blazing RS-25 Rocket Engines |
Sellas Life Quarterly Good Will |
|
Sellas Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sellas Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sellas Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Sellas Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sellas Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sellas Life Sciences backward and forwards among themselves. Sellas Life's institutional investor refers to the entity that pools money to purchase Sellas Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Springbok Capital Management, Llc | 2024-09-30 | 58.3 K | Lpl Financial Corp | 2024-09-30 | 51.9 K | Citadel Advisors Llc | 2024-09-30 | 47.3 K | Millennium Management Llc | 2024-09-30 | 46.3 K | Mariner Wealth Advisors Llc | 2024-06-30 | 44.9 K | Jane Street Group Llc | 2024-06-30 | 28 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 17.4 K | Two Sigma Investments Llc | 2024-09-30 | 16.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 16.2 K | Vanguard Group Inc | 2024-09-30 | 2.3 M | Anson Funds Management Lp | 2024-09-30 | 793.8 K |
Follow Sellas Life's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 82.35 M.Market Cap |
|
Project Sellas Life's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (8.67) | (9.11) | |
| Return On Capital Employed | 5.04 | 5.29 | |
| Return On Assets | (6.00) | (6.30) | |
| Return On Equity | 4.68 | 4.92 |
When accessing Sellas Life's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Sellas Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sellas Life's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Sellas Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sellas Life Sciences. Check Sellas Life's Beneish M Score to see the likelihood of Sellas Life's management manipulating its earnings.
Evaluate Sellas Life's management efficiency
Sellas Life Sciences has Return on Asset of (1.2915) % which means that on every $100 spent on assets, it lost $1.2915. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (8.8806) %, meaning that it generated no profit with money invested by stockholders. Sellas Life's management efficiency ratios could be used to measure how well Sellas Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sellas Life's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 4.92 in 2024, whereas Return On Tangible Assets are likely to drop (9.11) in 2024. At this time, Sellas Life's Intangibles To Total Assets are comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.07 in 2024, whereas Total Assets are likely to drop slightly above 5.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.29) | (0.27) | |
| Tangible Book Value Per Share | (0.36) | (0.34) | |
| Enterprise Value Over EBITDA | 52.59 | 55.22 | |
| Price Book Value Ratio | (3.69) | (3.51) | |
| Enterprise Value Multiple | 52.59 | 55.22 | |
| Price Fair Value | (3.69) | (3.51) | |
| Enterprise Value | 27.8 M | 26.4 M |
The decision-making processes within Sellas Life are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Enterprise Value Revenue 20.8445 | Quarterly Revenue Growth (0.82) | Return On Equity (8.88) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sellas Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sellas Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sellas Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kalin Katherine Bach over three months ago Acquisition by Kalin Katherine Bach of 19000 shares of Sellas Life subject to Rule 16b-3 | ||
Cicic Dragan over three months ago Disposition of 35000 shares by Cicic Dragan of Sellas Life at 1.89 subject to Rule 16b-3 | ||
Cicic Dragan over three months ago Disposition of 65000 shares by Cicic Dragan of Sellas Life at 0.5195 subject to Rule 16b-3 | ||
Jane Wasman over six months ago Acquisition by Jane Wasman of 25000 shares of Sellas Life at 1.38 subject to Rule 16b-3 | ||
Angelos Stergiou over six months ago Acquisition or disposition of Sellas Life securities by Angelos Stergiou | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 70000 shares of Sellas Life subject to Rule 16b-3 | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 450135 shares of Sellas Life subject to Rule 16b-3 | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 58000 shares of Sellas Life subject to Rule 16b-3 |
Sellas Life Earnings per Share Projection vs Actual
Sellas Life Corporate Management
| Barbara Esq | General VP | Profile | |
| Stacy Yeung | Associate VP | Profile | |
| Jrg Breitkopf | Head Operations | Profile | |
| ScD MD | President, Founder | Profile | |
| Barbara Wood | Gen VP | Profile | |
| Andrew Elnatan | Chemistry, Affairs | Profile | |
| Robert Francomano | Senior Officer | Profile |
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.